Hands on with Lenovo’s IdeaPad Yoga, a Windows 8 laptop/tablet hybrid (video)

Gaming execs: Join 180 select leaders from King, Glu, Rovio, Unity, Facebook, and more to plan your path to global domination in 2015. GamesBeat Summit is invite-only -- apply here. Ticket prices increase on April 3rd!

lenovo_ideapad_yogaLenovo has been busy at CES 2012 with debuts for smart TVs and laptops, but its coolest device may be the upcoming IdeaPad Yoga, a laptop that can bend over backwards and turn into a Windows 8 tablet.

With laptops beginning to model tablets in terms of thinness and lightness, it was only a matter of time before we began to see a model that blurs the line further by essentially being both. The IdeaPad Yoga is an Intel-powered thin-and-light Ultrabook laptop that mimics the MacBook Air when it is positioned like a laptop and mimics the iPad when it is set up like a tablet.

Lenovo product ambassader Ashley Perry walked me through the motions and showed me how the device’s hinges allow it to bend backwards and transform into a tablet. In a way, this takes after the dock-able IdeaPad S2 tablet, except it goes one further by being a combo device. Having the machine run Windows 8 also adds allure, because it’s still only available to developers.

I also got my hands on the device briefly and it was as cool as I expected it to be. The machine’s 13.3-inch screen with 10-finger touch was entertaining to try. The form factor itself is fun to play with too, but it was a little too heavy to use frequently as a tablet. The iPad is 1.5 pounds, while this thing is more than double that.

Lenovo expects the IdeaPad Yoga to ship when Windows 8 is available commercially, which should be in the third or fourth quarter of this year. The company expects the device to run for less than $1,200.

Watch the full IdeaPad Yoga hands on video below:

For more gadget news, be sure to check out VentureBeat’s live coverage from CES 2012.

VentureBeat’s VB Insight team is studying email marketing tools. Chime in here, and we’ll share the results.